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What does this review add to the existing literature and how will it influence future clinical 26 
practice? 27 
The population undergoing major lower limb amputation have a notorious association with 28 
mortality. Based on a systematic review of the literature, we show that 30-day and in-hospital 29 
mortality rates vary between 4 and 22% in population and regional-based studies. With the aim of 30 
providing direction for improvements in both clinical care and research, we demonstrate the need 31 
for detailed information to enable appropriate investigation of the relationship between population 32 
characteristics and post-operative mortality to better explain this variation. While it is currently 33 
unclear what these factors may be, it is clear that agreement through a coordinated process will 34 
improve current knowledge. 35 
 36 
37 
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Abstract 38 
Objectives: Lower limb amputation is a procedure frequently associated with a high risk of early 39 
post-operative mortality. Mortality rates are also increasingly being put forward as a possible 40 
benchmark for surgical performance. The primary aim of this systematic review is to investigate 41 
early post-operative mortality following a major lower limb amputation in 42 
population/regional-based studies, and reported factors that might influence these mortality 43 
outcomes.  44 
Design: Systematic review 45 
Methods: Embase, PubMed, Cinahl and Psycinfo were searched for publications in any language on 46 
30-day or in-hospital mortality after major lower limb amputation in population/regional-based 47 
studies. PRISMA-guidelines were followed. A self-developed checklist was used to assess quality and 48 
susceptibility to bias. We extracted summary data for percentage of population who died; pooling of 49 
quantitative results was not possible due to methodological differences between studies. 50 
Results: Of the 9082 publications identified, results from 21 were included. The percentage of the 51 
population undergoing amputation who died within 30-days ranged from 7-22%, the in-hospital 52 
equivalent was 4-20%. Transfemoral amputation and older age were found to have a higher 53 
proportion of early post-operative mortality, compared to transtibial and younger age respectively. 54 
Other patient factors or surgical treatment choices related with increased early post-operative 55 
mortality varied between studies. 56 
Conclusions: Early post-operative mortality rates vary from 4 to 22%. There is very limited data 57 
presented for patient-related factors (age, comorbidities) that influence mortality. Even less is 58 
known on factors related to surgical treatment choices, being limited to amputation level. More 59 
information is needed to enable any comparison across studies or for any benchmarking of 60 
acceptable mortality rates. Agreement on key factors to be reported needs to be agreed.  61 
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Introduction 65 
Major lower limb amputation is a procedure frequently associated as having a high risk of 66 
post-operative mortality.1-4 This is generally attributed to the relative older age and the high 67 
prevalence of cardiovascular comorbidities in the population undergoing the procedure, the 68 
amputation being a sign of end-stage disease and multi-organ failure; but it has also been labelled as 69 
a failure of care.5 Increasingly, data driven benchmarks for outcomes are requested by national 70 
bodies who seek to ensure standardised care for patients.6 However, it is not clear for the 71 
population with amputation what might be considered an acceptable outcome, including that of 72 
acceptable early post-operative mortality rates.  73 
 74 
A range of factors are thought to be related to post-operative mortality after amputation, including 75 
comorbidities (e.g. diabetes mellitus, cardiac disease or renal insufficiency), the setting in which the 76 
procedure takes place and a person’s status at the time of surgery. These factors may provide 77 
additional information about who is most at risk of dying within the population undergoing 78 
amputation. Highest early post-operative mortality percentages are seen in clinical practice for 79 
older patients and those undergoing amputation at the transfemoral level, but it is unknown if this 80 
difference is found consistently in population-based studies, as an overview of early post-operative 81 
mortality after major lower limb amputation based on a systematic review of the literature is not 82 
available. 83 
 84 
The risk of early post-operative mortality is an important consideration on which patients and 85 
surgeons base their decision firstly to undergo the procedure, and secondly the subsequent details 86 
such as level of the surgery. However, there is currently little consistency in the way data are 87 
presented. Summarising the published literature will aim to provide a minimal standard to which 88 
National registries, such as the UK vascular registry, can work to include relevant information. This 89 
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information might also provide useful benchmarks for comparing prognostic outcomes to gain a 90 
deeper understanding of factors contributing to mortality. 91 
 92 
The primary aim of this systematic review is to investigate early post-operative mortality following 93 
a major lower limb amputation in population or regional-based studies. Secondary aims are to 94 
evaluate what is known about the relationship between early post-operative mortality and reported 95 
factors that might influence these mortality outcomes. 96 
 97 
Materials and Methods 98 
This systematic review was performed according to the Preferred Reporting Items for Systematic 99 
Reviews and Meta-Analyses (PRISMA) guidelines7 and was prospectively registered at PROSPERO 100 
(CRD42012002241). 101 
 102 
Search strategy 103 
Because death is a frequent outcome within amputation populations, mortality is often included as a 104 
secondary outcome alongside a primary aim, for example, when a rehabilitation outcome is 105 
presented and a percentage of the population will have died in the time of follow up. In an effort to 106 
not immediately exclude such studies, the search strategy was purposefully designed to be broad 107 
and inclusive, using the terms: "Mortality OR Death OR Survival" AND "Amput*" and searching in all 108 
fields.   109 
 110 
Four databases were searched (Embase via OvidSP, PubMed, Cinahl, Psycinfo) including 111 
publications dated from 1 January 2000 to 30 July 2015, published in any language. The original 112 
search took place on 1 May 2012, and was updated on 30 July 2015 (see Figure 1). Publications that 113 
focused exclusively on amputations distal to the ankle joint (i.e. ‘minor amputations’ 8), or other 114 
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parts of body were excluded. Minor amputations were excluded as these are generally performed in 115 
a population with different mortality from those undergoing major amputation (e.g. 9-11). 116 
 117 
Study selection 118 
Two investigators (JVN and JH) independently screened all titles and abstracts for relevance to 119 
mortality or survival in a population with major lower limb amputation, from any cause. If either 120 
investigator scored the publication positively in the title phase, it was included to the next stage. 121 
Inclusion was based on: 1. Any incidence or population data (with an indication of a potential link to 122 
mortality); 2. Amputation is the primary outcome of a retrospective cohort study where the term 123 
'mortality' (or a synonym of) is mentioned; 3. Amputation versus other 'treatment' (e.g. limb 124 
salvage) where the term 'mortality' (or a synonym of) is mentioned. Abstracts were excluded if: 1. 125 
Amputation versus other 'treatment' (e.g. limb salvage) where the term 'mortality' (or a synonym 126 
of) is not mentioned; 2. The primary outcome is NOT amputation (e.g. primary outcome is other 127 
surgical procedure) and there is no immediate reference to amputation and mortality. In the 128 
abstract phase, differences on decisions for inclusion were discussed between the two investigators.  129 
 130 
Full text publications were independently screened by two investigators (LVF and JVN).  Early 131 
post-operative mortality was defined as either 30-day mortality (i.e. death within 30 days after the 132 
amputation operation date) or in-hospital mortality (i.e. death within the period of hospitalization 133 
immediately following the operation). Articles were included if early post-operative mortality was a 134 
primary outcome of the study. Only publications reporting data from population-based studies were 135 
included. Population-based was defined as any study across broad (regional or national) and 136 
well-defined populations, with numbers or percentages of key characteristics within this population 137 
presented. Data from single or selected centres was not considered reflective of the general 138 
population and therefore excluded. Foreign language articles were evaluated by a native speaker 139 
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who had experience in an academic or medical setting. None were included in the final set of 140 
publications. 141 
 142 
Quality and susceptibility to bias  143 
Since no specific quality assessment instrument was suited to our data and research aim, a 144 
self-developed approach had to be followed. In line with conclusions from a systematic review on 145 
tools for assessing the quality and susceptibility to bias in observational studies,12 a transparent 146 
checklist approach was chosen, concentrating on the few, principal, potential sources of bias. Our 147 
self-developed checklist was broadly based on the MOOSE guidelines13 and the Newcastle-Ottawa 148 
scale,14 and aimed to assess selection and information bias. Four criteria were assessed by two 149 
investigators (LVF and JVN) independently (Table 1). Each criterion was scored with a ‘+’, ‘?’, or ‘-‘. 150 
Disagreements were solved by discussion until consensus was reached. The criteria chosen were 151 
based primarily on the completeness of the population included, known to be an important aspect of 152 
bias in amputation research,15 and included the method of identifying information and the 153 
description of the population. Specific attention was given to reporting of amputation level as this is 154 
likely to impact on risk of mortality.  155 
 156 
Data extraction  157 
Data from each study was extracted by one investigator (JVN or LVF), after which the other 158 
investigator checked the extracted data. Data extracted concerned setting, country, period, number 159 
of patients, included levels of amputation, included population, percentage of the population with 160 
diabetes mellitus, amputations being the first-ever or any, age and gender of the population, 30-day 161 
or in-hospital mortality of all included patients and of specific subgroups per age, level, diabetes or 162 
no diabetes, and subgroups reported in multivariate analyses, including statistical values if 163 
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subgroups were compared. Authors were contacted if data to be extracted was unclear from the 164 
original publication. 165 
 166 
Results 167 
Of 9082 publications identified in the original and updated search, 22 publications met all inclusion 168 
criteria (Figure 1). Two publications reported findings from the same population using similar 169 
multivariate analyses;16,17 the publication that reported the most population details was included in 170 
the results.16 Presentation of data from 21 studies included contains eleven publications reporting 171 
30-day mortality, eight publications reporting in-hospital mortality, and two publications reporting 172 
both (Figure 1)1-4,9-11,16,18-30. Data and findings could not be pooled as the studies had differing 173 
inclusion and provided varied outcomes (i.e. no quantitative analyses were performed; Figure 1). 174 
Presented below are the major overarching findings of the included papers, with details of the 175 
original authors’ analyses presented in the tables. 176 
 177 
Data in included studies were collected through hospital records directly or through national 178 
surgical registries. Thirteen out of twenty-one publications presented data from United States (US) 179 
databases, with six publications presenting data obtained from the same database (American 180 
College of Surgeons National Surgical Quality Improvement Program [ACS NSQIP]) in the same time 181 
period. Three publications presented data from English Hospital Episode Statistics (HES) in the 182 
same time period. From the information presented on the populations included in these studies, 183 
potential overlap between studies reporting results of the same database could not be reliably 184 
determined, and as such descriptive data of all studies are given. To avoid analysing these data 185 
multiple times, results from these studies on the relation between mortality and patient factors will 186 
be reported separated from the other studies, as either “ACS NSQIP database” or “HES database”. 187 
 188 
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30-day mortality 189 
The susceptibility to bias of the thirteen included publications that reported 30-day mortality 190 
varied, with five publications meeting all four criteria, and three publications meeting only one 191 
(Table 2).  The number of included patients ranged from 299 to 186338. In terms of population 192 
studied, most publications included both transtibial and transfemoral amputations, exclusion 193 
criteria varied (e.g. none, terminal patients only, amputations as a result of cancer and trauma), 194 
population with diabetes ranged from 39 to 69%, inclusion of first amputation only or any 195 
amputation varied, and the population was generally older with a mean age >65 years (Table 2).  196 
 197 
30-day mortality ranged from 7 to 22% for all included patients (Table 3). 30-day mortality was 198 
lower after transtibial compared to transfemoral amputations, with differences ranging from 4-9% 199 
within studies (Table 3). This was found to be a statistically significant difference in the ACS NSQIP 200 
database and in the two other studies where this was tested (Table 3). No differences between 201 
30-day mortality in patients with and without diabetes were found in the ACS NSQIP database and 202 
two other studies (1-4% difference within studies, Table 3); a statistically significant lower 30-day 203 
mortality for patients with diabetes was found in one study (9% difference, p<0.05; Table 3).  204 
 205 
Variables related with 30-day mortality in multivariate analyses are shown in Supplementary Table 206 
1. Age at time of amputation was considered in the ACS NSQIP database and in two other studies. 207 
Older age was associated with higher mortality risk; the only exception was patients undergoing 208 
below-knee amputation in one study, although patients who died were significantly older in 209 
univariate analyses. Of the comorbidities investigated, patients with end-stage renal disease were 210 
found to have a higher mortality risk in the ACS NSQIP database and in patients undergoing 211 
below-knee amputation in one study; no significantly higher early post-operative mortality was 212 
found for patients with end-stage renal disease undergoing above-knee amputation in another 213 
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study. Cerebrovascular disease was significantly associated with higher mortality in the two studies 214 
that did investigate this; this was not investigated from the ACS NSQIP database. Concerning the 215 
patients’ status at the time of surgery, those who were totally dependent or with do not resuscitate 216 
order presented with higher 30-day mortality, as did those with pre-operative sepsis in the ACS 217 
NSQIP database.  218 
 219 
In-hospital mortality 220 
The susceptibility to bias of the ten included publications varied, with two publications meeting all 221 
four criteria, five publications meeting three out of four, and three meeting one or two out of four 222 
(Table 4). The number of included patients ranged from 2375 to 64710. In terms of population, all 223 
publications included both transtibial and transfemoral amputations, exclusion criteria varied (e.g. 224 
none, terminal patients only, amputations as a result of cancer and trauma), population with 225 
diabetes ranged from 39 to 89%, eight publications included any amputation, and the population 226 
was generally older with a mean age >65 years (Table 4). Mean or median length of stay ranged 227 
from 9 to 50 days, with high standard deviations (28-52), but length of stay was frequently not 228 
reported.  229 
 230 
In-hospital mortality ranged from 4-20% for all included patients (Table 5). In-hospital mortality 231 
was lower after transtibial compared to transfemoral amputations, with differences within studies 232 
ranging from 5-10% (Table 5); this was a statistically significant difference in the HES database and 233 
the three other publications where this was tested (Table 5). The difference between patients with 234 
or without diabetes was investigated in the HES database and one other study. Whereas a reduced 235 
in-hospital mortality risk for patients with diabetes was found in the HES database (Odd’s Ratio 0.55 236 
for men and 0.58 for women; Table 5), this difference was not significant in the other study.   237 
 238 
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Variables related with in-hospital mortality in multivariate analyses are shown in Supplementary 239 
Table 2. In the ACS NSQIP and HES databases and in two studies, older age was associated with 240 
higher mortality risk; the effect of age was not significant in one other study. Of the comorbidities 241 
investigated, patients with end-stage renal disease (ACS NSQIP and HES databases and one study) 242 
and patients with a higher score on the Charlson Comorbidity Index or higher illness severity (HES 243 
database and one study) were found to have a higher in-hospital mortality risk; this was found for 244 
patients with type 2 DM only in another study. Concerning the patients’ status at the time of surgery, 245 
those with systemic inflammatory response presented with higher in-hospital mortality in the ACS 246 
NSQIP database and two studies; this was not investigated in the HES database.  247 
 248 
Discussion 249 
Early post-operative mortality rates vary from 4 to 22% between studies. 1-4,9-11,16,18-30 In order to 250 
explain some of this variation, patient factors and surgical treatment options explored in the studies 251 
were extracted. These factors were not consistently or adequately reported in the studies, limiting 252 
our ability to fully investigate their influence on early post-operative mortality. Agreement across 253 
settings on key factors to be reported in future studies is recommended. A coordinated process, 254 
similar to that which other conditions have benefited from through initiatives like the Core Outcome 255 
Measures in Effectiveness Trials (COMET; http://www.comet-initiative.org) or the Outcome 256 
Measures in Rheumatology (OMERACT; http://www.omeract.org/), will increase current 257 
knowledge. At a minimum, reportable population factors that might be discussed in such a forum 258 
include: level of amputation, whether it was the first-ever or a subsequent amputation, the reason 259 
for amputation, the patient’s age and sex, and whether the amputation was performed as an 260 
emergency or planned procedure. Additionally, the distribution of age, sex and size of the general 261 
population, the geographical region and information on participating centres might be considered 262 
relevant for population-based studies, to better compare the different populations. However, until 263 
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such information is further explored, no definitive factors can be suggested. Agreement on factors to 264 
be included, and subsequent consistent reporting of these, is needed before early post-operative 265 
mortality rates can be considered for use as benchmark across settings. 266 
 267 
Influential patient factors (age, comorbidities) on mortality were inconsistent between studies. Age, 268 
end-stage renal disease, cerebrovascular disease, systemic inflammatory response at the time of 269 
operation, and being totally dependent on assistance for activities of daily living, were found as 270 
important factors in most, but not all, studies. As almost no study provided sufficient detail on early 271 
post-operative mortality for different subgroups, results of the studies could not be pooled or 272 
accurately compared for more detailed analysis of these findings. One major reason for this is that 273 
studies use different inclusion criteria. As an example, eighteen studies did not separate information 274 
for people undergoing their first major amputation and those having a subsequent major 275 
amputation. 2,4,9-11,16,18-21,23-30 This limits a fair comparison between two groups of patients that are 276 
different for surgeons when seen in clinical practice; people undergoing their first major 277 
amputation are likely to be in better condition than those undergoing subsequent amputation on the 278 
ipsilateral or contralateral limb. As the variables investigated for their influence on mortality were 279 
so varied, with only a few studies looking at the same patient factors or treatment parameters, we 280 
have presented qualitative and descriptive data from the studies in supplementary tables with the 281 
view that this information will demonstrate the need for improvements in reporting and gaps in 282 
current knowledge. The differences in early post-operative mortality found in the studies are 283 
discussed below with consideration to patient factors, surgical choices and treatment pathways. 284 
 285 
Within the population of patients undergoing an amputation, higher early post-operative mortality 286 
rates were found for those with a higher age.2-4,20,21,24,25,30 Within a population that is already old 287 
(mean age >65), the oldest patients had a higher mortality risk. Further, various underlying diseases 288 
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are found in the population undergoing amputation. Diabetes is a key factor of interest, which was 289 
reported to be present in 39-89% of the population in the included studies. The difference in the 290 
percentage of people with diabetes may be explained by inclusion criteria (e.g. the percentage of 291 
people with diabetes is known to be higher in transtibial amputations, and some studies included 292 
only transtibial amputations 21), as well as differences between countries and study settings. 293 
Findings on early post-operative mortality in relation to diabetes were mixed and inconclusive: no 294 
influence from diabetes on early post-operative mortality was found in the ACS NSQIP database and 295 
three studies,3,4,11,18,25 whereas in the HES database and one study lower early post-operative 296 
mortality percentages were found for people with diabetes.1,2 Findings on other patient factors 297 
varied greatly between studies and there was wide variation in the parameters investigated. 298 
End-stage renal disease, cerebrovascular disease, systemic inflammatory response at the time of 299 
operation, and being totally dependent on assistance for activities of daily living were the most 300 
frequently reported factors of interest. 301 
 302 
While population characteristics are present and unable to be modified by the time people are 303 
requiring amputation, there are choices around surgery and the treatment pathway that might also 304 
influence mortality. The most obvious of these is often considered to be the amputation level, with 305 
early post-operative mortality rates being lower after transtibial compared to transfemoral 306 
amputations.2,3,9,10,18,20,23,24,26,28-30 However, amputation at a lower level is also generally indicative of 307 
a less significant disease or infection process rather than simply a surgical choice. Not surprisingly, 308 
this additional level of health may provide protection from both a more proximal amputation and 309 
earlier mortality. Other factors around surgery and treatment pathway may also impact outcomes, 310 
including the timing of the operation, resources attributed in the pre-operative period to the person 311 
facing amputation, and the skills and experience of the surgical team. Timing of amputation has 312 
been linked to mortality, with risk of in-hospital death increasing by 2% for each day waited, and 313 
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well-planned elective amputations resulting in lower mortality risks than emergency amputations.2 314 
Another study found an association between the involvement of a surgical resident (i.e. during the 315 
surgical training period) and a higher percentage of adverse outcomes, although this might also be 316 
explained by their greater involvement in emergency operations.16,17 In the ideal setting, major 317 
amputations should be carefully planned and performed by an experienced surgical team, and 318 
consideration of these factors should be included in research outcomes. 319 
 320 
Looking further at the preoperative treatment pathway and the timing of amputation, recent 321 
perspectives have developed around being more aggressive with amputation, by operating sooner, 322 
choosing a more proximal level initially, or making a choice not to amputate at all. Continued 323 
attempts at limb salvage, through (endo-)vascular procedures, medications or prolonged 324 
hospitalisation and immobility may be disadvantageous to some patients.31 This perspective has 325 
been termed ‘choosing life or limb’,32 and provides reasoning that a person at risk needs to make an 326 
informed decision, ideally before their limb has reached a critical stage. Any change toward a more 327 
aggressive approach might lower early post-operative mortality, as people will be operated earlier 328 
in their life at a moment when concurrent cardiovascular disease might still be in an earlier stage. 329 
Such early intervention is not a new idea, having been used for the population with trauma who are 330 
considering limb salvage versus amputation,33 and for younger people with diabetes.34 For the older 331 
population with vascular disease, early amputation might reduce the lengthy periods of immobility 332 
and hospitalisation when attempts to heal the limb are pursued.31 It is during this time that a 333 
substantial decrease in physical condition and function can occur, leading to higher risk of mortality 334 
or, for those who survive, a reduced quality of life and poorer potential for good rehabilitation 335 
outcomes after an amputation.35,36,37 However, data underpinning these types of decisions was not 336 
available from any of the included studies. The preoperative treatment pathway and timing of 337 
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amputation should be further investigated and discussed to better understand its influence on 338 
amputation outcomes. 339 
 340 
For this systematic review we excluded a large number of studies that were not considered 341 
population/regional-based. While informative, these single centre studies are much more likely to 342 
be impacted by selection bias (particular in light of growing evidence of hospital/surgical influence 343 
on mortality outcomes). A limitation with this review is that sixteen of the twenty-one included 344 
studies were from the US or the UK, with the majority of the US studies coming from the same 345 
database (ACS NSQIP) and the same period (2005-2010). Another limitation is owing to healthcare 346 
databases and the availability of only selected information. For example, in ACS NSQIP functional 347 
status is only given in three levels, although more information on frailty and mobility limitations 348 
would be useful in this population. However, the basic information in these databases, and 349 
additional advantages of large population data, suffices when adequately reported information is 350 
included. 351 
 352 
In conclusion, early post-operative mortality rates in population/regional-based studies were found 353 
to vary from 4 to 22%. While there was some data presented for patient factors (age, comorbidities) 354 
that influence mortality, this was not consistent between studies. Even less is known on surgical 355 
treatment choices, being limited to the choice of amputation level. It is difficult to know what is 356 
really required with regard to minimally important factors or standard reporting. While we can 357 
make suggestions from clinical inferences of level of amputation, whether it was the first-ever or a 358 
subsequent amputation, the patient’s age and sex – we have no evidence if these are indeed what is 359 
required or what other factors might be required. Only with agreement on these key factors, and 360 
their consistent reporting, can we start to fully investigate the influences on early post-operative 361 
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mortality and subsequently, possibilities to lower this risk with surgical choices and changes in the 362 
treatment pathway. 363 
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Table 1: Overview of the system for quality and susceptibility to bias assessment of included studies 476 
 
A – Quality of description of included area or data sources  
+ Clear description of geographic region and participating centres in region or data sources. For 
example, data are presented for the size, sex, and age distribution of the population. Where relevant, 
providing complete referencing details to original data collection procedures or sources is adequate. 
? Unclear or incomplete description of geographical area, its residents and hospitals or data sources 
used. 
- No description of investigated area 
B – Quality of description of included population 
+ Clear description of in- and exclusion criteria are presented. Minimal criteria were considered sex, age 
and reason for amputation (the level of amputation is addressed separately.)  
? Unclear or incomplete description of in- and exclusion criteria 
- No description of in- and exclusion criteria 
C – Quality of description of level of amputation 
+ Clear description of the levels of amputation in line with international guidelines or codes, and a clear 
definition of whether amputations were the first, recurrent or any in sequence. 
? Unclear or incomplete description of levels of amputation in line with international guidelines or 
codes, or unclear or incomplete definition of sequence of amputation. 
- No description of levels of amputation or sequence of amputation. 
D – Quality of information source 
+ Source of information was complete, may include a combination of national health statistics and 
hospital records.   
Is information provided for when time to death was measured from – being admission, operation or 
discharge?  
Are the number of individuals at each stage of study reported – including number potentially eligible, 
number included, and number completed to follow-up?  
Were the number without an alive/death status identified? 
? Only national health statistics used, missing information for relevant time points. 
- Poor or no description given on data sources and missing all important information 
 477 
478 
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Table 2: Study and population characteristics of included studies reporting 30-day mortality after 479 
major lower limb amputation 480 
Study Population  
Setting, country Author Period n Levels 
included 








ty to bias 
ACS NSQIP; US Easterlin, 
2013 4 
2005-2009 9244 TT; KD; TF Excluded 
DNR/ 
terminal 
62 Any  66 62 + + - ? 
 Iannuzzi, 
2013 16 
2005-2010 11038 TT; TF All, no 
further 
description 
- - - 61 + - - ? 
 Karam, 
2013 18 
2005-2008 6839 BK; AK All, no 
further 
description 
61 - 67% aged 
>60 years 
62 + - ? ? 
 Davenport, 
2012 19 
2005-2009 6188 TT; TF DM and/or 
PAD only 
9 b Any  67 (14) 61 + + + + 
 Nelson, 
2012 20 
2005-2010 9368 TT; TF All TT: 69 
TF: 52 




+ + - ? 
 Belmont, 
2011 21 
2005 – 2008 2911 TT  - 68 Any 66 (14)  64 + + + ? 
Medicare; US Jones, 2013 
22  
2000-2008 186338 AD; TT; KD; 
TF; HD 




48 + + + ? 
Hospitals, NL Fortington, 
2013 3 
2003-2004 299 TT; KD; TF Vascular, 
infection 
and/or DM 









58 First  69 (12) 71 ? ? + ? 








P2: 4424 c 










Any P1: - 

































TF: 51  
 



















+ + + +  








First  TT: 66  
TF: 70 
100 + + + ? 
 481 
482 
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Note: ACS NSQIP = American College of Surgeons National Surgical Quality Improvement Program; DM = Diabetes 483 
Mellitus; DM1 = Type 1 DM; DM2 = Type 2 DM; PAD = peripheral artery disease; DNR = do not resuscitate; term = terminal 484 
cancer or chemotherapy; HES = Hospital Episode Statistics; NIS = Nationwide Inpatient Sample; VA = Veteran’s affairs; US 485 
= United States of America; NL = the Netherlands; PF/A = amputation distal to and including ankle; AD = ankle 486 
disarticulation; TT = transtibial; U-TT = unilateral TT; KD = knee disarticulation; TF = transfemoral; U-TF = unilateral TF; 487 
HD = hip disarticulation; BK = below knee; AK = above knee; P1 = period 1; P2 = period 2; P3 = period 3. -: information not 488 
presented, not presented for the whole population or includes population that were excluded. a: mean (standard 489 
deviation) unless indicated otherwise; b: number of patients with postoperative ICD-9 code representing DM, however, 490 
other codes (e.g. gangrene/sepsis or arterial disease) may also contain people with DM, but that information is not 491 
presented; c: mortality presented for number of amputations, not number of patients ; d: only data from this study on 492 
patients with major amputation, patients with toe or transmetatarsal amputation excluded.493 
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Table 3: 30-day mortality (in %) after major lower limb amputation 
Setting, country Author all TT TF Difference DM NoDM Difference 
ACS NSQIP; US Easterlin, 2013 4 8 - - - 8 9 1 
 Iannuzzi, 2013 16 9 - - - - - - 
 Karam, 2013 18 9 7 13 6 9 10 1 
 Davenport, 2012 19 8 - - - - - - 
 Nelson, 2012 20 - 7 13 6 TT: 6 
TF: 14 
- - 
 Belmont, 2011 21 7 - - - - - - 
Medicare; US Jones, 2013 22 14 - - - - - - 
Hospitals; NL Fortington, 2013 3 22 17 22 5 22 20 2 
Health insurance; 
Germany 
Icks, 2011 1 - - - - 10 19 9 
HES; England Vamos, 2010 11 P1: 14 
P2: 13 






















   
Veteran’s health 
administration 
Mayfield, 2001 23 - 7 11 4 - - - 
VA NSQIP; US Feinglass, 2001 24 - 6 13 7 - - - 
Note: numbers are percentages; ACS NSQIP = American College of Surgeons National Surgical Quality Improvement 
Program; DM = Diabetes Mellitus; DM1 = Type 1 DM; DM2 = Type 2 DM; HES = Hospital Episode Statistics; TT = transtibial 
amputation; TF = transfemoral amputation; VA = Veteran’s affairs; US = United States of America; NL = the Netherlands; 
UK = United Kingdom; P1 = period 1; P2 = period 2; P3 = period 3. Bold text indicates that a significant difference between 
groups was reported by the authors. 
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Table 4: Study and population characteristics of included studies reporting in-hospital mortality 
after major lower limb amputation 
Study Population    
Setting, 
country 
Author Period n Levels 
included 














Spain Lopez de 
Andres, 2015 
25 























? + + + 
Taiwan Mao, 2014 26 1997-2010 BK: 952 
AK: 168 
BK; AK PAD only BK: 89 
AK: 70 




- ? ? ? + 



















62 Any  66 62 - + + - + 
 Davenport, 
2012 19 




9 c Any  67 (14) 61 2005:  














44 Any 70 66 22 days 
(median) 
+ ? + + 
 Moxey, 2010 
28 
2003-2008 25578 b TT; KD; 
TF 























Bates, 2006 29 1 Oct 2002 
– 30 Sept 
2003  
2375 TT; TF; 
HD 





67 (11) 99 28.6 
(52.3) 






1991-1994 8696 TT; TF Circulatory 
system 
disorders 






+ ? ? + 
Note: ACS NSQIP = American College of Surgeons National Surgical Quality Improvement Program; DM = Diabetes 
Mellitus; DM1 = Type 1 DM; DM2 = Type 2 DM; PAD = peripheral artery disease; DNR = do not resuscitate; term = terminal 
cancer or chemotherapy; HES = Hospital Episode Statistics; VA = Veteran’s affairs; US = United States of America; TT = 
transtibial; KD = knee disarticulation; TF = transfemoral; HD = hip disarticulation; BK = below knee; AK = above knee; -: 
information not presented, not presented for the whole population or includes population that were excluded; a: mean 
(standard deviation); b: procedures, not number of patients; c: number of patients with postoperative ICD-9 code 
representing DM, however, other codes (e.g. gangrene/sepsis or arterial disease) may also contain people with DM, but 
that information is not presented. d: only data from this study on patients with amputation at the levels TT and TF 
included; e: ‘both’ concerns patients who underwent both TT and TF during the same hospital stay, without information on 
the most proximal amputation being ipsi- or contralateral. 
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Table 5: In-hospital mortality (in %) after major lower limb amputation 
Setting, country Author All TT TF Difference DM No DM 
Spain Lopez de Andres, 
2015 25 




Taiwan Mao, 2014 26 - 4 12 8 - - 
Germany Malyar, 2013 27 05: 20 
07: 20 
09: 19 
- - - - - 
ACS NSQIP; US Easterlin, 2013 4 5 - - - - - 
 Davenport, 2012 19 4 - - - - - 
HES; England Moxey, 2012 2 17 * * * ** ** 
 Moxey, 2010 28 17 12 22 10 - - 
Illinois non federal 
hospitals, US 








Treatment File; US 
Kazmers, 2000 30 13 10 17 7 - - 
Note: numbers are percentages or Odd’s ratios and 95% confidence intervals; ACS NSQIP = American College of Surgeons 
National Surgical Quality Improvement Program; DM = Diabetes Mellitus; DM1 = Type 1 DM; DM2 = Type 2 DM; HES = 
Hospital Episode Statistics; TT = transtibial amputation; TF = transfemoral amputation; VA = Veteran’s affairs; US = United 
States of America; Bold text indicates that a significant difference between groups was reported by the authors. *: Odd’s 
ratios (95%CI) of mortality for TF vs TT were 1.52 (1.28-1.80) for women and 1.48 (1.30-1.68). **: Odd’s ratios (95%CI) of 
mortality for DM vs noDM were 0.58 (0.49-0.70) for women and 0.55 (0.48-0.63) for men. 
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Figure 1: PRISMA flow chart 
 
 
 
  
